CD86 and Alzheimer disease: In this study, we showed that the B cell surface CD80, CD86, and CD40 expression in AD-HIES patients induced by R848 and CpG was significantly decreased than that in healthy controls, which implied the connection between STAT3 and TLRs-induced B cell activation.